Because we found that IL-21/IL-21R signaling in AML LSCs increases ROS and promotes proliferation and asymmetric division, we hypothesized that IL-21 could render AML LSCs more susceptible for chemotherapy. The gene discussed is IL21R; the disease is acute myeloid leukemia.